首页|期刊导航|BIOCELL|12-O-Tetradecanoylphorbol-13-Acetate Inhibits TGF-β1-Induced Proliferation and Fibrosis in LX-2 Hepatic Stellate Cells by Regulating both YAP and AKT Activities

12-O-Tetradecanoylphorbol-13-Acetate Inhibits TGF-β1-Induced Proliferation and Fibrosis in LX-2 Hepatic Stellate Cells by Regulating both YAP and AKT ActivitiesOA

中文摘要

Background:Although transforming growth factor-β(TGF-β)drives hepatic stellate cell activation and fibrogenesis,the mechanisms by which 12-O-tetradecanoylphorbol-13-acetate(TPA)modulates these processes in TGF-β1-activated hepatic stellate cells remain to be determined.Therefore,we investigated whether TPA alleviates fibrosis in TGF-β1-treated hepatic stellate cells and regulates both canonical and non-canonical pathways.Further,we assessed whether inhibitors of these pathways similarly affect proliferation and fibrosis in LX-2 cells.Methods:LX-2 hepatic stellate cells were used as the experimental model.Cells were treated with TPA,TGF-β,or TGF-β plus TPA,and Yes-associated protein(YAP)and protein kinase B(PKB;AKT)phosphorylation,as well as YAP intracellular localization,were assessed.PKC-δ involvement was examined using the pan-PKC inhibitor Go 6983,and the roles of YAP and AKT in TGF-β1-activated LX-2 cells were evaluated using verteporfin and AKTI-1/2,respectively.Results:TPA significantly increased YAP phosphorylation and reduced its nuclear translocation,resulting in decreased LX-2 cell proliferation and fibronectin(FN1)production.Although TPA also inhibited AKT phosphorylation,FN1 expression was primarily regulated by YAP inhibition.Notably,proliferation in TGF-β1-treated LX-2 cells was suppressed only upon co-administration of both inhibitors.Our results suggest that coordinated regulation of YAP and AKT activity is essential for controlling fibroblast proliferation and ECM production.Conclusions:These findings suggest that in TGF-β-activated hepatic stellate cells,YAP simultaneously controls proliferation and fibrosis,and AKT regulates only proliferation.Therefore,TPA,which regulates both YAP and AKT activity,may be a promising therapeutic candidate for liver fibrosis treatment by simultaneously controlling proliferation and fibrosis in hepatic stellate cells.

Moo Hyun Kim;Yongdae Yoon;Chang Wan Kim;Jun-Won Lee;Bhupendra Regmi;Saher Fatima;Moon Young Kim;Soon Koo Baik;Pil Young Jung;Young Woo Eom

Department of Surgery,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaDepartment of Surgery,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaDepartment of Internal Medicine,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of Korea Department of Internal Medicine,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of Korea Department of Internal Medicine,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaDepartment of Surgery,Yonsei University Wonju College of Medicine,Wonju,Republic of KoreaRegeneration Medicine Research Center,Yonsei University Wonju College of Medicine,Wonju,Republic of Korea

医药卫生

12-O-tetradecanoylphorbol-13-acetateyes-associated proteinprotein kinase Bhepatic stellate celltransforming growth factor-β1

《BIOCELL》 2026 (6)

P.206-219,14

funded by the Basic Science Research Program through the National Research Foundation of Korea(NRF),grant numbers RS-2023-00250982 and 2021R1I1A1A01056265.

10.32604/biocell.2026.076364

评论